rabeprazole

Ukraine

Drugs containing this active substance

  • BAROL 10

    The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.

    Form: capsules, enteric-coated

    Active substance Dosage
    rabeprazole 10 mg

    ATC: A02BC04

    Manufacturer: Intervetia Helskeia Ltd

  • The drug is used for the treatment of gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibiotics.

    Form: capsules, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Intervetia Helskeia Ltd

  • The drug is used to treat gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibiotics.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 10 mg

    ATC: A02BC04

    Manufacturer: Mepro Pharmaceuticals Private Limited

  • The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Mepro Pharmaceuticals Private Limited

  • The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger–Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 10 mg

    ATC: A02BC04

    Manufacturer: Bosch Pharmaceuticals Ltd. (manufacturing of unpackaged product)

  • The drug is used for the treatment of peptic gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibacterial agents.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Bosch Pharmaceuticals Ltd. (manufacturing of unpackaged product)

  • The drug is used in cases where oral administration is not possible. It is prescribed for the exacerbation of gastric or duodenal ulcers with bleeding, for the short-term treatment of reflux disease with erosions, for the prevention of acid reflux into the esophagus, as well as for Zollinger–Ellison syndrome.

    Form: lyophilisate for solution for injection

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Cadila Pharmaceuticals Limited

  • The drug is used for the treatment of gastric and duodenal peptic ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori in combination with antibacterial agents.

    Form: tablets, film-coated, enteric-coated

    Active substance Dosage
    rabeprazole 10 mg

    ATC: A02BC04

    Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)

  • The drug is used for the treatment of peptic gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.

    Form: tablets, film-coated, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: LLC "Corporation "Zdorovya" (all manufacturing stages, quality control, batch release)

  • The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger–Ellison syndrome. It is also used for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Laboratorios Legalsa, S.A. (manufacturing of medicinal product, primary and secondary packaging, batch quality control, responsible for batch release)

  • The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger–Ellison syndrome. It is also used to eradicate Helicobacter pylori bacteria in combination with antibiotics.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Tulip Lab Pvt. Ltd.

  • The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibiotics.

    Form: tablets, coated, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Macleods Pharmaceuticals Limited

  • The drug is used for the treatment of gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori bacteria in combination with antibacterial agents.

    Form: tablets, coated, enteric-coated

    Active substance Dosage
    rabeprazole 10 mg

    ATC: A02BC04

    Manufacturer: Macleods Pharmaceuticals Limited

  • The drug is used for the treatment of peptic gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, as well as for the eradication of Helicobacter pylori in combination with antibiotics.

    Form: tablets, coated, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: Torrent Pharmaceuticals Ltd

  • The drug is used to treat gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used to eradicate Helicobacter pylori bacteria in combination with antibiotics.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 20 mg

    ATC: A02BC04

    Manufacturer: KRKA, d.d., Novo mesto (responsible for manufacturing 'in bulk', primary and secondary packaging, batch control and batch release)

  • The drug is used to treat gastric and duodenal ulcers, erosive or ulcerative gastroesophageal reflux disease (GERD), as well as Zollinger-Ellison syndrome. It is also used to eradicate Helicobacter pylori in combination with antibiotics.

    Form: tablets, enteric-coated

    Active substance Dosage
    rabeprazole 10 mg

    ATC: A02BC04

    Manufacturer: KRKA, d.d., Novo mesto (responsible for manufacturing 'in bulk', primary and secondary packaging, batch control and batch release)